<DOC>
	<DOCNO>NCT03096834</DOCNO>
	<brief_summary>The purpose study determine AMG 334 effective treat migraine patient unsuccessfully fail preventive migraine treatment .</brief_summary>
	<brief_title>A Study Evaluating Effectiveness AMG 334 Injection Preventing Migraines Adults Having Failed Other Therapies</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Documented history migraine 12 month prior screen 414 day per month migraine symptom &gt; =80 % diary compliance Baseline period Failure previous migraine prophylactic treatment &gt; 50 year old migraine onset Pregnant nursing History cluster hemiplegic headache Evidence seizure psychiatric disorder Score 19 high BDI Active chronic pain syndrome Cardiac hepatic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Migraine</keyword>
	<keyword>attack</keyword>
	<keyword>headache</keyword>
	<keyword>episodic</keyword>
	<keyword>aura</keyword>
	<keyword>AMG 334</keyword>
	<keyword>CGRP receptor agonist</keyword>
	<keyword>erenumab</keyword>
</DOC>